Dietmar Berger
Chief Medical Officer · GILEAD SCIENCES, INC.
Individual
- 2026
- Sep 11, 2026
- 4
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Dietmar Berger files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Daniel Patrick O'Day - $51.19M in GILD purchases and sales in the last 12 months
- Johanna Mercier - $18.17M in GILD purchases and sales in the last 12 months
- Deborah H. Telman - $6.59M in GILD purchases and sales in the last 12 months
- Andrew D. Dickinson - $4.38M in GILD purchases and sales in the last 12 months
- Anthony Welters - $2.68M in GILD purchases and sales in the last 12 months
- Jeffrey Bluestone - $1.35M in GILD purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Dietmar Berger?
Dietmar Berger is a corporate insider, tracked as Chief Medical Officer of GILEAD SCIENCES, INC. (GILD). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Dietmar Berger submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
